NewsBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.39055.671481.DB (Published 07 December 2006) Cite this as: BMJ 2006;333:1188
Pfizer halts trial of heart drug after deaths:The drug giant Pfizer has stopped the trial of its drug torcetrapid, which is designed to increase HDL cholesterol concentrations, after scientists monitoring the trial noted that 82 people taking the drug along with the company's statin, atorvastatin (Lipitor), had died, whereas 51 people taking Lipitor alone had died. Pfizer had been expected to apply for a licence for …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial